Paliogianni F, Raptis A, Ahuja S S, Najjar S M, Boumpas D T
Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
J Clin Invest. 1993 Apr;91(4):1481-9. doi: 10.1172/JCI116353.
IL-2 gene transcription is affected by several nuclear proteins. We asked whether dexamethasone (Dex) and cyclosporin A (CsA) inhibit IL-2 gene transcription by interfering with the activity of nuclear proteins that bind to the IL-2 promoter. Nuclear extracts from primary human T lymphocytes were analyzed by electrophoretic DNA mobility shift assays. Both Dex and CsA inhibited the binding of transcription factors AP-1 and NF-AT, but not of NF-kB and OCT-1/OAF, to their corresponding sites on the IL-2 gene promoter. To correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections. Jurkat cells were transfected with plasmids containing either the intact IL-2 promoter or its AP-1, NF-AT, and NF-kB motifs. Dex inhibited the IL-2 promoter and the AP-1, but not the NF-AT and NF-kB plasmids. In contrast, CsA inhibited the IL-2 promoter and the NF-AT, but not the AP-1 and NF-kB plasmids. These results suggest that in human T lymphocytes both Dex and CsA inhibited IL-2 gene transcription through interference with transcription factors AP-1 and NF-AT. We propose that, while maximum inhibition may involve interaction with both transcription factors, AP-1 is the primary target of Dex.
白细胞介素-2(IL-2)基因转录受多种核蛋白影响。我们探究地塞米松(Dex)和环孢素A(CsA)是否通过干扰与IL-2启动子结合的核蛋白活性来抑制IL-2基因转录。采用电泳DNA迁移率变动分析对原代人T淋巴细胞的核提取物进行分析。Dex和CsA均抑制转录因子AP-1和活化T细胞核因子(NF-AT)与IL-2基因启动子上相应位点的结合,但不抑制核因子κB(NF-κB)和八聚体转录因子1/Octamer结合转录激活因子(OCT-1/OAF)与相应位点的结合。为了将体外核因子结合变化与体内转录活性相关联,并确定IL-2启动子抑制的结构要求,我们进行了瞬时DNA转染。用含有完整IL-2启动子或其AP-1、NF-AT和NF-κB基序的质粒转染Jurkat细胞。Dex抑制IL-2启动子和AP-1质粒,但不抑制NF-AT和NF-κB质粒。相反,CsA抑制IL-2启动子和NF-AT质粒,但不抑制AP-1和NF-κB质粒。这些结果表明,在人T淋巴细胞中,Dex和CsA均通过干扰转录因子AP-1和NF-AT来抑制IL-2基因转录。我们提出,虽然最大抑制可能涉及与两种转录因子的相互作用,但AP-1是Dex的主要作用靶点。